Summary
The influence of food intake on the bioavailability of the beta-adrenoceptor blocker atenolol was assessed by measurement of its single-dose kinetics in ten healthy volunteers, who took 100 mg both in the fasting state and together with a standardized breakfast. Food intake significantly shortened the time to reach peak concentration (2.7 h vs 1.5 h), but caused a significant reduction in AUC values, the mean decrease being 20%. The elimination half-life was unaffected. Atenolol, which is relatively hydrophilic, is incompletely absorbed in the fasting state, and escapes first-pass metabolism. The present findings indicate that food intake causes further impairment of its absorption, even though the absorption rate may initially be enhanced. This contrasts with previous observations on the more lipophilic beta-adrenoceptor blockers propranolol and metoprolol.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Melander, A.: Influence of food on the bioavailability of drugs. Clin. Pharmacokinet.3, 337–351 (1978)
Melander, A., Brante, G., Johansson, Ö., Lindberg, T., Wåhlin-Boll, E.: Influence of food intake on the absorption of phenytoin. Eur. J. Clin. Pharmacol.15, 269–274 (1979)
Levy, R. H., Pitlick, W. H., Troupin, A. S., Green, J. R., Neal, J. M.: Pharmacokinetics of carbamazepine in normal man. Clin. Pharmacol. Ther.17, 657–668 (1975)
Melander, A., Wåhlin, E.: Enhancement of dicoumarol bioavailability by concomitant food intake. Eur. J. Clin. Pharmacol.14, 441–444 (1978)
Beermann, B., Groschinsky-Grind, M.: Gastrointestinal absorption of hydrochlorothiazide enhanced by concomitant intake of food. Eur. J. Clin. Pharmacol. (in press)
Melander, A., Danielson, K., Scherstén, B., Thulin, T., Wåhlin, E.: Enhancement by food of canrenone bioavailability from spironolactone. Clin. Pharmacol. Ther.22, 100–103 (1977)
Bates, T. R., Sequeira, J. A., Tembo, A. V.: Effect of food on nitrofurantoin absorption. Clin. Pharmacol. Ther.16, 63–68 (1974)
Malmborg, A.-S.: Absorption of erythromycin stearate after oral administration. Curr. Med. Res. Opin. 5 (Suppl. 2), 15–18 (1978)
Melander, A., Danielson, K., Hanson, A., Jansson, L., Rerup, C., Scherstén, B., Thulin, T., Wåhlin, E.: Reduction of isoniazid bioavailability in normal men by concomitant intake of food. Acta Med. Scand.200, 93–97 (1976)
Acocella, G.: Clinical pharmacokinetics of rifampicin. Clin. Pharmacokinet.3, 128–143 (1978)
Melander, A., Danielson, K., Scherstén, B., Wåhlin, E.: Enhancement of the bioavailability of propranolol and metoprolol by food. Clin. Pharmacol. Ther.22, 108–112 (1977)
Johnsson, G., Regårdh, C.-G.: Clinical pharmacokinetics of beta-adrenoceptor blocking drugs. Clin. Pharmacokinet.1, 233–263 (1976)
McLean, A. J., McNamara, P. J., duSouich, P., Gibaldi, M., Lalka, D.: Food, splancnic blood flow, and bioavailability of drugs subject to first-pass metabolism. Clin. Pharmacol. Ther.24, 5–10 (1978)
Cotham, R. H., Shand, D.: Spuriously low plasma propranolol concentrations resulting from blood collection methods. Clin. Pharmacol. Ther.18, 535–538 (1975)
Scales, G., Copsey, H.: The gas chromatographic determination of atenolol in biological samples. J. Pharm. Pharmacol.27, 430–433 (1975)
Hörnkvist, P. E. (ICI-Pharma, Sweden), personal communication
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Melander, A., Stenberg, P., Liedholm, H. et al. Food-induced reduction in bioavailability of atenolol. Eur J Clin Pharmacol 16, 327–330 (1979). https://doi.org/10.1007/BF00605630
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00605630